scorecardresearch
Follow Us:
Sunday, August 09, 2020

Prabha Raghavan

Profile

$150-mn shot for Serum production of Covid vaccines
Sat, Aug 08, 2020

Production to be scaled up through $150 million in at-risk funds from the Bill and Melinda Gates Foundation

Of 17 sites for SII’s Oxford vaccine human trials, eight located in Maharashtra
Sat, Aug 08, 2020

In Maharashtra, four of the sites will be in Pune, two in Mumbai and one each in Nagpur and Wardha. Two sites will be in Chennai, while Visakhapatnam, Mysore, Jodhpur, Patna, Chandigarh, New Delhi and Gorakhpur will have one site each for the trials.

Trump order boosts US drug industry, no hit on India exports in short term: Experts
Sat, Aug 08, 2020

Several experts said the move appeared to be either posturing by Trump before the presidential election in November, or to be targeted essentially at China which, unlike India, is a larger exporter of key drug ingredients.

Explained: Will Trump’s order to buy American medicines impact Indian pharma industry?
Sun, Aug 09, 2020

The US is the largest market for India’s pharmaceutical products. It is said that every third pill sold in America is made in India.

Auto to aviation, employee costs take the biggest hit
Fri, Aug 07, 2020

InterGlobe Aviation, the parent company of IndiGo, reduced its employee costs by 14.8% during the quarter, compared with the same period last year, while net revenues from operations fell 92% year-on-year during the quarter.

Health Minister petitioned: Medical professionals seek transparency in pharma regulations
Fri, Aug 07, 2020

The move comes at a time when various drugmakers and vaccine firms have received approvals to either conduct clinical trials or launch their products in the country for use in the battle against Covid-19.

As it prepares for Oxford vaccine trials, Serum Institute inks deal for another Covid-19 shot
Fri, Aug 07, 2020

The agreement will give SII exclusive right to supply the vaccine in India, and non-exclusive rights, “during the pandemic period”, in all countries except those designated by the World Bank as “upper-middle or high-income” countries.

Recruiters to trainees, veterans, the services sector bears brunt
Wed, Aug 05, 2020

From food to aviation, and IT to hospitality, the decimation caused by the economic distress is echoing across the services sector, which is estimated to employ over 33 per cent of the employed population and contribute over 55 per cent to the GDP.

Covid-19 vaccine makers seek more govt support, clarity on guidelines
Wed, Aug 05, 2020

Countries like the US and UK have not only inked purchase agreements worth billions of dollars for vaccine candidates currently in late stage human clinical trials, some have also funded research and development for potential vaccine candidates.

Explained: Significance of having the Oxford phase-III vaccine trials in India
Thu, Aug 06, 2020

In clinical trials for any new drug or vaccine, the third phase of testing looks for the effectiveness of the product in thousands of participants. India has the second largest population in the world, making it crucial for this demographic to be represented in these trials.

Explained: Why are so many vaccines being developed all at the same time?
Tue, Aug 04, 2020

Vaccine development is a complex, time-consuming, resource-intensive process, and the chances of success are extremely low.

July harder than June, migrants out of work hit economic wall at home
Tue, Aug 04, 2020

A key bellwether of activity in the manufacturing sector slipped in July after two months of steady growth reflecting the adverse impact of localised lockdowns by states to fight the surging Covid curve.

Frontrunner Oxford vaccine for Covid-19 cleared for advanced trial in India
Tue, Aug 04, 2020

SII, the world's largest maker of vaccines, has a tie-up with AstraZeneca, the Swedish-British pharma giant, to manufacture the Covid-19 vaccine for low- and middle-income countries.

Explained: Why the race for a Covid-19 vaccine is an unprecedented sprint
Mon, Aug 03, 2020

Why has the coronavirus pandemic spawned one of the hottest vaccine races in history? The Indian Express delves into the details.

Serum Institute gets nod for Phase 2, 3 human trials of Oxford vaccine candidate
Mon, Aug 03, 2020

Now that the chief of the Central Drugs Standard Control Organisation has signed off on the proposal, as confirmed by the health ministry Monday, SII will be able to kick-off the trials here, effectively putting it ahead in India’s own race for a Covid-19 vaccine.

Eggs to cutting-edge tech: Vaccine makers upgrade their pandemic response
Mon, Aug 03, 2020

The SARS-CoV-2 virus, that causes COVID-19, does not replicate in embryonated eggs, according to a study published in the Euro Surveillance journal.

Explained: Will the import restrictions on televisions push up prices?
Mon, Aug 03, 2020

TV Import Restrictions: The move is especially expected to wean India off its import dependence on China for various electronic goods. The Indian Express takes a look at the decision and what this will mean for consumers.

Panel recommends nod to Serum for late-stage Oxford vaccine trials
Sat, Aug 01, 2020

The development comes three days after the Subject Expert Committee (SEC) for Covid-related therapies on Tuesday recommended amendments to Serum’s earlier protocol to conduct the trials here.

Panel studying Serum Institute’s request to start late-stage human trials in India defers decision
Thu, Jul 30, 2020

According to minutes of a meeting held by the Subject Expert Committee for Covid-19 on Tuesday, Serum has been told to submit a “revised protocol” for evaluation.

ICMR plans national registry of Covid patients to help improve treatment
Thu, Jul 30, 2020

The project, a national clinical registry, will also serve as a crucial platform to conduct clinical trials to study the effectiveness of newer therapies being used as part of treatment for this disease.

Oxford Covid-19 vaccine candidate trials in India: Pune firm asked to revise proposal
Thu, Jul 30, 2020

Serum Institute of India has a tie-up with AstraZeneca and is expected to produce around a billion doses of the vaccine for low- and middle-income countries next year.

Renu Swarup: ‘Confident that we will have a safe and effective indigenous vaccine’
Wed, Jul 29, 2020

Globally, the non-replicating viral vector-based vaccine from Oxford-AstraZeneca and one inactivated alum platform from SinoVac are the leads being in Phase III.

Amidst race for vaccine, govt readies trial sites, detailed data on volunteers
Tue, Jul 28, 2020

Locating the right volunteers — who have not been infected with Covid-19 earlier, are not asymptomatic and are healthy — has been a problem in conducting clinical trials.

Covaxin gets DSMB nod to continue human trials
Tue, Jul 28, 2020

Clinical trial sites studying the safety and effectiveness of Covaxin were recently given permission by the Data and Safety Monitoring Board (DSMB) to continue recruiting participants for the trial after it reviewed data from the first 50 participants that were vaccinated, they said.

Oxford vaccine: CDSCO may take up SII request for human trials this week
Mon, Jul 27, 2020

On Saturday, the Pune-headquartered firm approached the Central Drugs Standard Control Organisation (CDSCO) with its application to conduct late stage clinical trials for the vaccine candidate, said a senior government official in the know.

Advertisement
Advertisement
Advertisement
Advertisement